Advertisement

Search Results

Advertisement



Your search for Monique Hartley-Brown, MD, MMSc,Monique Hartley-Brown, MD, MMSc matches 1 pages

Showing 1 - 1


multiple myeloma
immunotherapy

Daratumumab in Front-Line Treatment of Newly Diagnosed Transplant-Ineligible Multiple Myeloma: Questions Emerge From MAIA Trial

In the past decade, use of immunotherapy has arisen as a novel adjunct to multiple myeloma therapy. Daratumumab is the first anti-CD38 monoclonal antibody to be approved by the U.S. Food and Drug Administration (FDA), in November 2015, for use in treating relapsed or refractory multiple myeloma.1...

Advertisement

Advertisement



Advertisement